Gemcitabine/Platinum Containing Regimens as Preoperative Chemotherapy for Patients With Non Small Cell Lung Cancer

• Status: Completed
• Trial end date: 2006-07-01
• Target enrollment: 0
• Participant gender: All

Summary

To study the efficacy and tolerability of gemcitabine/platinum chemotherapy in non small cell lung cancer

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Eli Lilly and Company
• Treatments: Carboplatin; Cisplatin; Gemcitabine

Criteria

Inclusion Criteria:

• Histologically of cytologically confirmed non small cell lung cancer

• No prior chemotherapy or radiation

• No prior malignancy

Exclusion Criteria:

• Pregnant or breastfeeding

• Serious concomitant systemic disorder